Franța - franceză - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

novartis pharma sas - carbamazépine 400 mg - comprimé - 400 mg - pour un comprimé > carbamazépine 400 mg - antiepileptique, dérivé du carboxamide - classe pharmacothérapeutique - code atc : antiepileptique, dérivé du carboxamide - n03af01tegretol appartient à une classe de médicaments appelés les antiépileptiques.il est utilisé pour traiter : certaines formes d’épilepsie et de convulsionstegretol est utilisé pour traiter différentes formes d’épilepsie ou de convulsions chez les adultes et les enfants. ce médicament peut être pris seul ou en association avec un autre médicament antiépileptique. certains troubles de l’humeurdans ce cas, tegretol est utilisé quand le traitement par un autre médicament (notamment le lithium) n’a pas fonctionné ou ne peut pas être utilisé. certains types de douleurso des douleurs au niveau du visage provoquées par une maladie des nerfs de la face (névralgies du trijumeau et du glossopharyngien).o des douleurs neuropathiques périphériques chez un adulte.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 20 mg/ml;  ;   - syrup - 100 mg/5ml - active: carbamazepine 20 mg/ml     excipient: caramel hyetellose macrogol stearate 400 methyl hydroxybenzoate powdered cellulose propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 20 mg/ml;   - syrup - 100 mg/5ml - active: carbamazepine 20 mg/ml   excipient: caramel hyetellose macrogol stearate 400 methyl hydroxybenzoate powdered cellulose propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 200mg;  ;   - tablet - 200 mg - active: carbamazepine 200mg     excipient: carmellose sodium colloidal silicon dioxide magnesium stearate microcrystalline cellulose - · epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 400mg;   - tablet - 400 mg - active: carbamazepine 400mg   excipient: carmellose sodium colloidal silicon dioxide magnesium stearate microcrystalline cellulose - · epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 200mg;  ;   - modified release tablet - 200 mg - active: carbamazepine 200mg     excipient: carmellose sodium colloidal silicon dioxide ethylcellulose hypromellose yellow, red, white suspension iron oxide red iron oxide yellow magnesium stearate methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil purified talc   purified water titanium dioxide - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 400mg;   - modified release tablet - 400 mg - active: carbamazepine 400mg   excipient: carmellose sodium colloidal silicon dioxide ethylcellulose hypromellose yellow, red, white suspension iron oxide red iron oxide yellow magnesium stearate methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil purified talc   purified water titanium dioxide - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

Spania - spaniolă - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

novartis farmaceutica s.a. - carbamazepina - comprimido - 200 mg - carbamazepina 200 mg - carbamazepina

Spania - spaniolă - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

novartis farmaceutica s.a. - carbamazepina - comprimido - 400 mg - carbamazepina 400 mg - carbamazepina

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

novartis pharma ag - carbamazepinum - comprimate - 200 mg